Home LiteratureArticle Details
PMID: 15302859 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Bcl-2 homodimerization involves two distinct binding surfaces, a topographic arrangement that provides an effective mechanism for Bcl-2 to capture activated Bax.

The Journal of biological chemistry ·Vol. 279 ·No. 42 ·2004-10-15 ·Pages 43920-8

Zhang Z, Lapolla SM, Annis MG, Truscott M, Roberts GJ, Miao Y, Shao Y, Tan C, Peng J, Johnson AE, Zhang XC, Andrews DW, Lin J

Abstract

The homo- and heterodimerization of Bcl-2 family proteins is important for transduction and integration of apoptotic signals and control of the permeability of mitochondria and endoplasmic reticulum membranes. Here we mapped the interface of the Bcl-2 homodimer in a cell-free system using site-specific photocross-linking. Bcl-2 homodimer-specific photoadducts were detected from 11 of 17 sites studied. When modeled into the structure of Bcl-2 core, the interface is composed of two distinct surfaces: an acceptor surface that includes the hydrophobic groove made by helices 2 and 8 and the loop connecting helices 4 and 5 and a donor surface that is made by helices 1-4 and the loop connecting helices 2 and 3. The two binding surfaces are on separate faces of the three-dimensional structure, explaining the formation of Bcl-2 homodimers, homo-oligomers, and Bcl-2/Bax hetero-oligomers. We show that in vitro the Bcl-2 dimer can still interact with activated Bax as a larger oligomer. However, formation of a Bax/Bcl-2 heterodimer is favored, since this interaction inhibits Bcl-2 homodimerization. Our data support a simple model mechanism by which Bcl-2 interacts with activated Bax during apoptosis in an effective manner to neutralize the proapoptotic activity of Bax.

MeSH Terms
Apoptosis/physiology Binding Sites Cell Line Dimerization Gene Deletion Humans Mutagenesis Protein Conformation Proto-Oncogene Proteins c-bcl-2/chemistry,genetics,metabolism Recombinant Proteins/chemistry,metabolism Sequence Deletion Transfection bcl-2-Associated X Protein
Chemicals
BAX protein, human Proto-Oncogene Proteins c-bcl-2 Recombinant Proteins bcl-2-Associated X Protein
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Zhang Zhi
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City 73190, USA.
Lapolla Suzanne M
Annis Matthew G
Truscott Mary
Roberts G Jane
Miao Yiwei
Shao Yuanlong
Tan Chibing
Peng Jun
Johnson Arthur E
Zhang Xuejun C
Andrews David W
Lin Jialing
References (61)
61 references, click to expand
  1. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    J Biol Chem. 1996 Mar 29;271(13):7440-4 PMID: 8631771
  2. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death.
    Nature. 1996 May 23;381(6580):335-41 PMID: 8692274
  3. Bcl-2 mutants with restricted subcellular location reveal spatially distinct pathways for apoptosis in different cell types.
    EMBO J. 1996 Aug 15;15(16):4130-41 PMID: 8861942
  4. BID: a novel BH3 domain-only death agonist.
    Genes Dev. 1996 Nov 15;10(22):2859-69 PMID: 8918887
  5. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis.
    Science. 1997 Feb 14;275(5302):983-6 PMID: 9020082
  6. A common binding site mediates heterodimerization and homodimerization of Bcl-2 family members.
    J Biol Chem. 1997 Apr 25;272(17):11350-5 PMID: 9111042
  7. Nonionic detergents induce dimerization among members of the Bcl-2 family.
    J Biol Chem. 1997 May 23;272(21):13829-34 PMID: 9153240
  8. Double identity for proteins of the Bcl-2 family.
    Nature. 1997 Jun 19;387(6635):773-6 PMID: 9194558
  9. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity.
    J Biol Chem. 1997 Sep 26;272(39):24101-4 PMID: 9305851
  10. Bcl-2 counters apoptosis by Bax heterodimerization-dependent and -independent mechanisms in the T-cell lineage.
    J Biol Chem. 1997 Nov 14;272(46):29347-55 PMID: 9361016
  11. Bim: a novel member of the Bcl-2 family that promotes apoptosis.
    EMBO J. 1998 Jan 15;17(2):384-95 PMID: 9430630
  12. The conserved N-terminal BH4 domain of Bcl-2 homologues is essential for inhibition of apoptosis and interaction with CED-4.
    EMBO J. 1998 Feb 16;17(4):1029-39 PMID: 9463381
  13. Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent caspase-9 activation.
    Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4386-91 PMID: 9539746
  14. Mutagenesis of the BH3 domain of BAX identifies residues critical for dimerization and killing.
    Mol Cell Biol. 1998 Oct;18(10):6083-9 PMID: 9742125
  15. Signal sequence recognition in posttranslational protein transport across the yeast ER membrane.
    Cell. 1998 Sep 18;94(6):795-807 PMID: 9753326
  16. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
    EMBO J. 1999 Feb 1;18(3):632-43 PMID: 9927423
  17. Solution structure of BID, an intracellular amplifier of apoptotic signaling.
    Cell. 1999 Mar 5;96(5):615-24 PMID: 10089877
  18. Solution structure of the proapoptotic molecule BID: a structural basis for apoptotic agonists and antagonists.
    Cell. 1999 Mar 5;96(5):625-34 PMID: 10089878
  19. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3100-5 PMID: 10737788
  20. The interaction of the chaperonin tailless complex polypeptide 1 (TCP1) ring complex (TRiC) with ribosome-bound nascent chains examined using photo-cross-linking.
    J Cell Biol. 2000 May 1;149(3):591-602 PMID: 10791973
  21. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c.
    Genes Dev. 2000 Aug 15;14(16):2060-71 PMID: 10950869
  22. Structure of Bax: coregulation of dimer formation and intracellular localization.
    Cell. 2000 Nov 10;103(4):645-54 PMID: 11106734
  23. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies.
    Protein Sci. 2000 Dec;9(12):2528-34 PMID: 11206074
  24. Solution structure of the antiapoptotic protein bcl-2.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3012-7 PMID: 11248023
  25. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells.
    J Biol Chem. 2001 Apr 13;276(15):11615-23 PMID: 11136736
  26. Biophysical characterization of recombinant human Bcl-2 and its interactions with an inhibitory ligand, antimycin A.
    Biochemistry. 2001 Apr 24;40(16):4911-22 PMID: 11305906
  27. Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane.
    J Biol Chem. 2001 May 25;276(21):18361-74 PMID: 11279112
  28. The cellular protein PRA1 modulates the anti-apoptotic activity of Epstein-Barr virus BHRF1, a homologue of Bcl-2, through direct interaction.
    J Biol Chem. 2001 Jul 20;276(29):27354-62 PMID: 11373297
  29. Cytoplasmic O-glycosylation prevents cell surface transport of E-cadherin during apoptosis.
    EMBO J. 2001 Nov 1;20(21):5999-6007 PMID: 11689440
  30. Membrane topography and topogenesis of prenylated Rab acceptor (PRA1).
    J Biol Chem. 2001 Nov 9;276(45):41733-41 PMID: 11535589
  31. Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis.
    Nat Cell Biol. 2003 Jan;5(1):28-37 PMID: 12510191
  32. Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras.
    J Biol Chem. 2003 Feb 21;278(8):5775-85 PMID: 12477721
  33. The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity.
    EMBO J. 2003 Apr 1;22(7):1497-507 PMID: 12660157
  34. p53 has a direct apoptogenic role at the mitochondria.
    Mol Cell. 2003 Mar;11(3):577-90 PMID: 12667443
  35. Mechanisms of cytochrome c release by proapoptotic BCL-2 family members.
    Biochem Biophys Res Commun. 2003 May 9;304(3):437-44 PMID: 12729577
  36. Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix.
    J Biol Chem. 2003 Jun 6;278(23):21124-8 PMID: 12651847
  37. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function.
    Immunity. 2003 Sep;19(3):341-52 PMID: 14499110
  38. A multimeric model for murine anti-apoptotic protein Bcl-2 and structural insights for its regulation by post-translational modification.
    J Mol Model. 2003 Oct;9(5):298-303 PMID: 14517609
  39. Cotranslational protein integration into the ER membrane is mediated by the binding of nascent chains to translocon proteins.
    Mol Cell. 2003 Aug;12(2):329-41 PMID: 14536073
  40. Unique structural features of a BCL-2 family protein CED-9 and biophysical characterization of CED-9/EGL-1 interactions.
    Cell Death Differ. 2003 Dec;10(12):1310-9 PMID: 12894216
  41. Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis.
    J Biol Chem. 2003 Dec 5;278(49):48935-41 PMID: 14522999
  42. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3.
    Cell. 2004 Feb 20;116(4):527-40 PMID: 14980220
  43. Structural biology of the Bcl-2 family of proteins.
    Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94 PMID: 14996493
  44. Control of mitochondrial permeability by Bcl-2 family members.
    Biochim Biophys Acta. 2004 Mar 1;1644(2-3):107-13 PMID: 14996495
  45. There is more to life and death than mitochondria: Bcl-2 proteins at the endoplasmic reticulum.
    Biochim Biophys Acta. 2004 Mar 1;1644(2-3):115-23 PMID: 14996496
  46. Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers.
    EMBO J. 2004 May 19;23(10):2146-55 PMID: 15131699
  47. During apoptosis bcl-2 changes membrane topology at both the endoplasmic reticulum and mitochondria.
    Mol Cell. 2004 May 21;14(4):523-9 PMID: 15149601
  48. Photocrosslinking of the signal sequence of nascent preprolactin to the 54-kilodalton polypeptide of the signal recognition particle.
    Proc Natl Acad Sci U S A. 1986 Nov;83(22):8604-8 PMID: 3095839
  49. Site-directed mutagenesis by overlap extension using the polymerase chain reaction.
    Gene. 1989 Apr 15;77(1):51-9 PMID: 2744487
  50. Both the 5' untranslated region and the sequences surrounding the start site contribute to efficient initiation of translation in vitro.
    Mol Cell Biol. 1991 May;11(5):2656-64 PMID: 2017171
  51. The signal sequence moves through a ribosomal tunnel into a noncytoplasmic aqueous environment at the ER membrane early in translocation.
    Cell. 1993 Jun 18;73(6):1101-15 PMID: 8513496
  52. New photolabeling and crosslinking methods.
    Annu Rev Biochem. 1993;62:483-514 PMID: 8352595
  53. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.
    Cell. 1993 Aug 27;74(4):609-19 PMID: 8358790
  54. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Nature. 1994 May 26;369(6478):321-3 PMID: 8183370
  55. Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system.
    Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9238-42 PMID: 7937747
  56. Bad, a heterodimeric partner for Bcl-XL and Bcl-2, displaces Bax and promotes cell death.
    Cell. 1995 Jan 27;80(2):285-91 PMID: 7834748
  57. Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bcl-2 and heterodimerization with Bax.
    J Biol Chem. 1995 May 19;270(20):11962-9 PMID: 7744846
  58. Multiple Bcl-2 family members demonstrate selective dimerizations with Bax.
    Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7834-8 PMID: 7644501
  59. Apoptosis. A sticky business.
    Curr Biol. 1995 Jun 1;5(6):622-4 PMID: 7552172
  60. Bax-independent inhibition of apoptosis by Bcl-XL.
    Nature. 1996 Feb 8;379(6565):554-6 PMID: 8596636
  61. The cotranslational integration of membrane proteins into the phospholipid bilayer is a multistep process.
    Cell. 1996 May 3;85(3):369-78 PMID: 8616892
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2004-10-15
Epub
2004-00-09
Pages
43920-8
Language
English
Region
United States
NLM ID
2985121R
PMCID
PMC1350923
Subset
IM
Grants
NIGMS NIH HHS · R01 GM062964 · United States
NIGMS NIH HHS · GM062964 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com